
Global Opioid Narcotics Industry Growth and Trends Forecast to 2031
Description
Summary
According to APO Research, The global Opioid Narcotics market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Opioid Narcotics include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Reig Jofre, Pfizer, GSK and Fresenius Kabi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Opioid Narcotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Narcotics.
The Opioid Narcotics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioid Narcotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Opioid Narcotics Segment by Company
Yichang Renfu Pharmaceutical Co., Ltd.
Jiangsu Enhua Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical Co., Ltd.
Sinopharm Group Industrial Co., Ltd. Langfang Branch
Changzhou Siyao Pharmaceutical Co., Ltd.
Reig Jofre
Pfizer
GSK
Fresenius Kabi
Daiichi Sankyo
AcelRx Pharmaceuticals, Inc
Abbott
Opioid Narcotics Segment by Type
Fentanyl
Remifentanil
Sufentanil
Opioid Narcotics Segment by Application
Hospital
Clinic
Other
Opioid Narcotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Narcotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Narcotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Narcotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Opioid Narcotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Opioid Narcotics market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Opioid Narcotics include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Reig Jofre, Pfizer, GSK and Fresenius Kabi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Opioid Narcotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Narcotics.
The Opioid Narcotics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioid Narcotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Opioid Narcotics Segment by Company
Yichang Renfu Pharmaceutical Co., Ltd.
Jiangsu Enhua Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical Co., Ltd.
Sinopharm Group Industrial Co., Ltd. Langfang Branch
Changzhou Siyao Pharmaceutical Co., Ltd.
Reig Jofre
Pfizer
GSK
Fresenius Kabi
Daiichi Sankyo
AcelRx Pharmaceuticals, Inc
Abbott
Opioid Narcotics Segment by Type
Fentanyl
Remifentanil
Sufentanil
Opioid Narcotics Segment by Application
Hospital
Clinic
Other
Opioid Narcotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Narcotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Narcotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Narcotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Opioid Narcotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
100 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Opioid Narcotics Market Size Estimates and Forecasts (2020-2031)
- 1.2.2 Global Opioid Narcotics Sales Estimates and Forecasts (2020-2031)
- 1.3 Opioid Narcotics Market by Type
- 1.3.1 Fentanyl
- 1.3.2 Remifentanil
- 1.3.3 Sufentanil
- 1.4 Global Opioid Narcotics Market Size by Type
- 1.4.1 Global Opioid Narcotics Market Size Overview by Type (2020-2031)
- 1.4.2 Global Opioid Narcotics Historic Market Size Review by Type (2020-2025)
- 1.4.3 Global Opioid Narcotics Forecasted Market Size by Type (2026-2031)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Opioid Narcotics Sales Breakdown by Type (2020-2025)
- 1.5.2 Europe Opioid Narcotics Sales Breakdown by Type (2020-2025)
- 1.5.3 Asia-Pacific Opioid Narcotics Sales Breakdown by Type (2020-2025)
- 1.5.4 South America Opioid Narcotics Sales Breakdown by Type (2020-2025)
- 1.5.5 Middle East and Africa Opioid Narcotics Sales Breakdown by Type (2020-2025)
- 2 Global Market Dynamics
- 2.1 Opioid Narcotics Industry Trends
- 2.2 Opioid Narcotics Industry Drivers
- 2.3 Opioid Narcotics Industry Opportunities and Challenges
- 2.4 Opioid Narcotics Industry Restraints
- 3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Opioid Narcotics Revenue (2020-2025)
- 3.2 Global Top Players by Opioid Narcotics Sales (2020-2025)
- 3.3 Global Top Players by Opioid Narcotics Price (2020-2025)
- 3.4 Global Opioid Narcotics Industry Company Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Opioid Narcotics Major Company Production Sites & Headquarters
- 3.6 Global Opioid Narcotics Company, Product Type & Application
- 3.7 Global Opioid Narcotics Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Opioid Narcotics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Opioid Narcotics Players Market Share by Revenue in 2024
- 3.8.3 2023 Opioid Narcotics Tier 1, Tier 2, and Tier 3
- 4 Opioid Narcotics Regional Status and Outlook
- 4.1 Global Opioid Narcotics Market Size and CAGR by Region: 2020 VS 2024 VS 2031
- 4.2 Global Opioid Narcotics Historic Market Size by Region
- 4.2.1 Global Opioid Narcotics Sales in Volume by Region (2020-2025)
- 4.2.2 Global Opioid Narcotics Sales in Value by Region (2020-2025)
- 4.2.3 Global Opioid Narcotics Sales (Volume & Value), Price and Gross Margin (2020-2025)
- 4.3 Global Opioid Narcotics Forecasted Market Size by Region
- 4.3.1 Global Opioid Narcotics Sales in Volume by Region (2026-2031)
- 4.3.2 Global Opioid Narcotics Sales in Value by Region (2026-2031)
- 4.3.3 Global Opioid Narcotics Sales (Volume & Value), Price and Gross Margin (2026-2031)
- 5 Opioid Narcotics by Application
- 5.1 Opioid Narcotics Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Opioid Narcotics Market Size by Application
- 5.2.1 Global Opioid Narcotics Market Size Overview by Application (2020-2031)
- 5.2.2 Global Opioid Narcotics Historic Market Size Review by Application (2020-2025)
- 5.2.3 Global Opioid Narcotics Forecasted Market Size by Application (2026-2031)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Opioid Narcotics Sales Breakdown by Application (2020-2025)
- 5.3.2 Europe Opioid Narcotics Sales Breakdown by Application (2020-2025)
- 5.3.3 Asia-Pacific Opioid Narcotics Sales Breakdown by Application (2020-2025)
- 5.3.4 South America Opioid Narcotics Sales Breakdown by Application (2020-2025)
- 5.3.5 Middle East and Africa Opioid Narcotics Sales Breakdown by Application (2020-2025)
- 6 Company Profiles
- 6.1 Yichang Renfu Pharmaceutical Co., Ltd.
- 6.1.1 Yichang Renfu Pharmaceutical Co., Ltd. Comapny Information
- 6.1.2 Yichang Renfu Pharmaceutical Co., Ltd. Business Overview
- 6.1.3 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
- 6.1.4 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
- 6.1.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
- 6.2 Jiangsu Enhua Pharmaceutical Co., Ltd.
- 6.2.1 Jiangsu Enhua Pharmaceutical Co., Ltd. Comapny Information
- 6.2.2 Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview
- 6.2.3 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
- 6.2.4 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
- 6.2.5 Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Developments
- 6.3 Henan Lingrui Pharmaceutical Co., Ltd.
- 6.3.1 Henan Lingrui Pharmaceutical Co., Ltd. Comapny Information
- 6.3.2 Henan Lingrui Pharmaceutical Co., Ltd. Business Overview
- 6.3.3 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
- 6.3.4 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
- 6.3.5 Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments
- 6.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch
- 6.4.1 Sinopharm Group Industrial Co., Ltd. Langfang Branch Comapny Information
- 6.4.2 Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview
- 6.4.3 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
- 6.4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio
- 6.4.5 Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Developments
- 6.5 Changzhou Siyao Pharmaceutical Co., Ltd.
- 6.5.1 Changzhou Siyao Pharmaceutical Co., Ltd. Comapny Information
- 6.5.2 Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview
- 6.5.3 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
- 6.5.4 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
- 6.5.5 Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments
- 6.6 Reig Jofre
- 6.6.1 Reig Jofre Comapny Information
- 6.6.2 Reig Jofre Business Overview
- 6.6.3 Reig Jofre Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
- 6.6.4 Reig Jofre Opioid Narcotics Product Portfolio
- 6.6.5 Reig Jofre Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Comapny Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
- 6.7.4 Pfizer Opioid Narcotics Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 GSK
- 6.8.1 GSK Comapny Information
- 6.8.2 GSK Business Overview
- 6.8.3 GSK Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
- 6.8.4 GSK Opioid Narcotics Product Portfolio
- 6.8.5 GSK Recent Developments
- 6.9 Fresenius Kabi
- 6.9.1 Fresenius Kabi Comapny Information
- 6.9.2 Fresenius Kabi Business Overview
- 6.9.3 Fresenius Kabi Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
- 6.9.4 Fresenius Kabi Opioid Narcotics Product Portfolio
- 6.9.5 Fresenius Kabi Recent Developments
- 6.10 Daiichi Sankyo
- 6.10.1 Daiichi Sankyo Comapny Information
- 6.10.2 Daiichi Sankyo Business Overview
- 6.10.3 Daiichi Sankyo Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
- 6.10.4 Daiichi Sankyo Opioid Narcotics Product Portfolio
- 6.10.5 Daiichi Sankyo Recent Developments
- 6.11 AcelRx Pharmaceuticals, Inc
- 6.11.1 AcelRx Pharmaceuticals, Inc Comapny Information
- 6.11.2 AcelRx Pharmaceuticals, Inc Business Overview
- 6.11.3 AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
- 6.11.4 AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio
- 6.11.5 AcelRx Pharmaceuticals, Inc Recent Developments
- 6.12 Abbott
- 6.12.1 Abbott Comapny Information
- 6.12.2 Abbott Business Overview
- 6.12.3 Abbott Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
- 6.12.4 Abbott Opioid Narcotics Product Portfolio
- 6.12.5 Abbott Recent Developments
- 7 North America by Country
- 7.1 North America Opioid Narcotics Sales by Country
- 7.1.1 North America Opioid Narcotics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.1.2 North America Opioid Narcotics Sales by Country (2020-2025)
- 7.1.3 North America Opioid Narcotics Sales Forecast by Country (2026-2031)
- 7.2 North America Opioid Narcotics Market Size by Country
- 7.2.1 North America Opioid Narcotics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2.2 North America Opioid Narcotics Market Size by Country (2020-2025)
- 7.2.3 North America Opioid Narcotics Market Size Forecast by Country (2026-2031)
- 8 Europe by Country
- 8.1 Europe Opioid Narcotics Sales by Country
- 8.1.1 Europe Opioid Narcotics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.1.2 Europe Opioid Narcotics Sales by Country (2020-2025)
- 8.1.3 Europe Opioid Narcotics Sales Forecast by Country (2026-2031)
- 8.2 Europe Opioid Narcotics Market Size by Country
- 8.2.1 Europe Opioid Narcotics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2.2 Europe Opioid Narcotics Market Size by Country (2020-2025)
- 8.2.3 Europe Opioid Narcotics Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific by Country
- 9.1 Asia-Pacific Opioid Narcotics Sales by Country
- 9.1.1 Asia-Pacific Opioid Narcotics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.1.2 Asia-Pacific Opioid Narcotics Sales by Country (2020-2025)
- 9.1.3 Asia-Pacific Opioid Narcotics Sales Forecast by Country (2026-2031)
- 9.2 Asia-Pacific Opioid Narcotics Market Size by Country
- 9.2.1 Asia-Pacific Opioid Narcotics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2.2 Asia-Pacific Opioid Narcotics Market Size by Country (2020-2025)
- 9.2.3 Asia-Pacific Opioid Narcotics Market Size Forecast by Country (2026-2031)
- 10 South America by Country
- 10.1 South America Opioid Narcotics Sales by Country
- 10.1.1 South America Opioid Narcotics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.1.2 South America Opioid Narcotics Sales by Country (2020-2025)
- 10.1.3 South America Opioid Narcotics Sales Forecast by Country (2026-2031)
- 10.2 South America Opioid Narcotics Market Size by Country
- 10.2.1 South America Opioid Narcotics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2.2 South America Opioid Narcotics Market Size by Country (2020-2025)
- 10.2.3 South America Opioid Narcotics Market Size Forecast by Country (2026-2031)
- 11 Middle East and Africa by Country
- 11.1 Middle East and Africa Opioid Narcotics Sales by Country
- 11.1.1 Middle East and Africa Opioid Narcotics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.1.2 Middle East and Africa Opioid Narcotics Sales by Country (2020-2025)
- 11.1.3 Middle East and Africa Opioid Narcotics Sales Forecast by Country (2026-2031)
- 11.2 Middle East and Africa Opioid Narcotics Market Size by Country
- 11.2.1 Middle East and Africa Opioid Narcotics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2.2 Middle East and Africa Opioid Narcotics Market Size by Country (2020-2025)
- 11.2.3 Middle East and Africa Opioid Narcotics Market Size Forecast by Country (2026-2031)
- 12 Value Chain and Sales Channels Analysis
- 12.1 Opioid Narcotics Value Chain Analysis
- 12.1.1 Opioid Narcotics Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Opioid Narcotics Production Mode & Process
- 12.2 Opioid Narcotics Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Opioid Narcotics Distributors
- 12.2.3 Opioid Narcotics Customers
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.